4//SEC Filing
Partridge Andrew John 4
Accession 0001209191-20-042407
CIK 0001595893other
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 5:40 PM ET
Size
7.4 KB
Accession
0001209191-20-042407
Insider Transaction Report
Form 4
Partridge Andrew John
EVP & Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2020-07-13+127,500→ 127,500 totalExercise: $59.94Exp: 2030-07-12→ Common Stock (127,500 underlying) - Award
Common Stock
2020-07-13+21,500→ 21,500 total
Footnotes (2)
- [F1]Represents restricted stock unit award granted under the Issuer's 2019 Equity Incentive Plan.
- [F2]25% of the shares vest on July 13, 2021 and 1/48th of the shares vest monthly thereafter over the next three years.
Documents
Issuer
Turning Point Therapeutics, Inc.
CIK 0001595893
Entity typeother
Related Parties
1- filerCIK 0001758838
Filing Metadata
- Form type
- 4
- Filed
- Jul 13, 8:00 PM ET
- Accepted
- Jul 14, 5:40 PM ET
- Size
- 7.4 KB